Litcius/Paper detail

Lipase elevation and type 1 diabetes mellitus related to immune checkpoint inhibitor therapy – A multicentre study of 90 patients from the German Dermatooncology Group

Imke Grimmelmann, M Momma, Lisa Zimmer, Jessica C. Hassel, Lucie Heinzerling, Claudia Pföhler, Carmen Loquai, Cristel Ruini, Jochen Utikal, Kai‐Martin Thoms, Katharina C. Kähler, Thomas Eigentler, Rudolf Herbst, Friedegund Meier, Dirk Debus, Carola Berking, Corinna Kochanek, Selma Ugurel, Ralf Gutzmer

2021European Journal of Cancer26 citationsDOIOpen Access PDF

Topics & Concepts

MedicinePancreatitisInternal medicineLipaseDiabetes mellitusGastroenterologyDiscontinuationAdverse effectKetoacidosisEndocrinologyType 1 diabetesChemistryEnzymeBiochemistryCancer Immunotherapy and BiomarkersPancreatic and Hepatic Oncology ResearchAdvanced Breast Cancer Therapies
Lipase elevation and type 1 diabetes mellitus related to immune checkpoint inhibitor therapy – A multicentre study of 90 patients from the German Dermatooncology Group | Litcius